FDA Approved: DESOXIMETASONE — Supplemental Application (Saptalis Pharmaceuticals, LLC.)

View source ↗

Summary

FDA approved a supplemental application for desoximetasone (Saptalis Pharmaceuticals, LLC.), resulting in updated labeling for this topical corticosteroid.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis
• Contact Dermatitis
• Dermatitis
• Psoriasis

Drugs mentioned

• Desoximetasone (Desoximetasone)

Snippet

SUPPL AP for DESOXIMETASONE (DESOXIMETASONE)